Significant variations between NHS hospitals in adverse outcomes for treatment of breast cancer — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/03/140321095232.htm
source : http://www.sciencedaily.com/releases/2014/03/140321095232.htm
source : http://www.sciencedaily.com/releases/2014/03/140313212631.htm
source : http://www.sciencedaily.com/releases/2014/02/140227134704.htm
source : http://www.sciencedaily.com/releases/2014/02/140225122506.htm
source : http://www.sciencedaily.com/releases/2014/02/140207083727.htm
But the society has also warned that a worrying lack of information about the situation in Eastern Europe must be urgently addressed. Published in the Annals of Oncology this week, the survey provides the first detailed information on the current number of medical oncologists in 12 European Union countries, mostly in Western Europe, and their predicted availability by 2020. Around the world countries are struggling to ensure their medical oncology systems can deal with the increase in cancer cases, says ESMO Press Officer Solange Peters, a lung cancer expert from the university of Lausanne, Switzerland. Until now, nobody could say what the situation was in Europe. …
The study, to be published Dec. 8 online in the journal Nature Methods, shows that the scientists’ targeted protein-detection approach has the potential to systematically and reliably measure the entire human repertoire of proteins, known as the proteome. …
The findings are important because lowering the cell cycle progression (CCP) score may help prevent prostate cancers from becoming more aggressive, said study lead author William Aronson, a clinical professor of urology at UCLA and chief of urologic oncology at the West Los Angeles Veterans Affairs Medical Center. "We found that CCP scores were significantly lower in the prostate cancer in men who consumed the low-fat fish oil diet as compare to men who followed a higher fat Western diet," Aronson said…
The results offer some of the first evidence for the existence of distinct EBV subtypes with very different public health risks. …
For decades, scientists have experimented with using nerve grafts as a way of bridging the spinal cord injury site in an attempt to recover lost function following spinal cord injury. However, coaxing these cells to grow and form connections capable of relaying nerve signals has been elusive. In the current study, Yu-Shang Lee, PhD, of the Cleveland Clinic, together with Jerry Silver, PhD, of Case Western Reserve Medical School, and others, used a chemical that promotes cell growth along with a scar-busting enzyme to create a more hospitable environment for the nerve graft at the injury site. …